Ignite Creation Date:
2025-12-24 @ 2:41 PM
Ignite Modification Date:
2026-03-10 @ 11:51 PM
Study NCT ID:
NCT02488759
Status:
COMPLETED
Last Update Posted:
2023-11-13
First Post:
2015-06-30
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
An Investigational Immuno-therapy Study to Investigate the Safety and Effectiveness of Nivolumab, and Nivolumab Combination Therapy in Virus-associated Tumors
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-10-13
Start Date Type:
ACTUAL
Primary Completion Date:
2021-03-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-10-24
Completion Date Type:
ACTUAL
First Submit Date:
2015-06-30
First Submit QC Date:
None
Study First Post Date:
2015-07-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-03-17
Results First Submit QC Date:
None
Results First Post Date:
2022-04-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-11-08
Last Update Post Date:
2023-11-13
Last Update Post Date Type:
ACTUAL